Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation

2019 ◽  
Vol 51 (10) ◽  
pp. 3437-3443
Author(s):  
Shun Fujiwara ◽  
Norimichi Hattori ◽  
Tomoharu Matsui ◽  
Ayaka Nakata ◽  
Yohei Sasaki ◽  
...  
Keyword(s):  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Hematological Malignancies ◽  
Disease Risk ◽  
Risk Index ◽  
Rare Disorders

scholarly journals Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Blood ◽  
2014 ◽  
Vol 123 (23) ◽  
pp. 3664-3671 ◽  
Author(s):  
Philippe Armand ◽  
Haesook T. Kim ◽  
Brent R. Logan ◽  
Zhiwei Wang ◽  
Edwin P. Alyea ◽  
...  
Keyword(s):  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Disease Risk ◽  
Risk Index ◽  
Allogeneic Transplantation ◽  
Key Points ◽  
Conditioning Intensity

Key Points The DRI successfully stratified patients in a very large allogeneic transplantation registry cohort. The DRI was refined by using this cohort to build a more inclusive and conditioning intensity–independent index.

Validating the Allogeneic Stem Cell Transplantation Disease Risk Index

2015 ◽  
Vol 99 (1) ◽  
pp. 128-132 ◽  
Author(s):  
Andrew B.M. Lim ◽  
Andrew W. Roberts ◽  
Kate Mason ◽  
Ashish Bajel ◽  
Jeff Szer ◽  
...  
Keyword(s):  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Disease Risk ◽  
Risk Index
Sign in / Sign up

Export Citation Format

Share Document